Galecto Future Growth
Future criteria checks 0/6
Galecto's earnings are forecast to decline at 28.2% per annum while its annual revenue is expected to grow at 91% per year. EPS is expected to decline by 26.2% per annum.
Key information
-28.2%
Earnings growth rate
-26.2%
EPS growth rate
Biotechs earnings growth | 27.6% |
Revenue growth rate | 91.0% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 01 Nov 2024 |
Recent future growth updates
Recent updates
Is Galecto (NASDAQ:GLTO) In A Good Position To Invest In Growth?
Jan 10Here's Why Galecto (NASDAQ:GLTO) Must Use Its Cash Wisely
May 17Will Galecto (NASDAQ:GLTO) Spend Its Cash Wisely?
Feb 01Galecto’s GB1211 to be studied for phase 2 trial in combination with pembrolizumab to treat cancer
Oct 19Here's Why We're Watching Galecto's (NASDAQ:GLTO) Cash Burn Situation
Oct 19Galecto GAAP EPS of -$0.67 beats by $0.02
Jul 29We're Keeping An Eye On Galecto's (NASDAQ:GLTO) Cash Burn Rate
Jun 30Is Galecto (NASDAQ:GLTO) In A Good Position To Deliver On Growth Plans?
Mar 10Galecto: Selling At Cash Value
Dec 19We're Keeping An Eye On Galecto's (NASDAQ:GLTO) Cash Burn Rate
Nov 18Here's Why We're Watching Galecto's (NASDAQ:GLTO) Cash Burn Situation
Jul 07Galecto EPS misses by $0.07
May 04We Think Galecto (NASDAQ:GLTO) Can Afford To Drive Business Growth
Mar 23Do Institutions Own Galecto, Inc. (NASDAQ:GLTO) Shares?
Jan 29Galecto EPS misses by $41.65
Dec 11Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | N/A | -38 | N/A | N/A | 1 |
12/31/2025 | N/A | -20 | N/A | N/A | 1 |
12/31/2024 | N/A | -18 | N/A | N/A | 1 |
9/30/2024 | N/A | -21 | -25 | -25 | N/A |
6/30/2024 | N/A | -25 | -30 | -30 | N/A |
3/31/2024 | N/A | -31 | -34 | -34 | N/A |
12/31/2023 | N/A | -38 | -37 | -37 | N/A |
9/30/2023 | N/A | -46 | -37 | -37 | N/A |
6/30/2023 | N/A | -52 | -38 | -38 | N/A |
3/31/2023 | N/A | -58 | -45 | -45 | N/A |
12/31/2022 | N/A | -62 | -43 | -43 | N/A |
9/30/2022 | N/A | -61 | -49 | -49 | N/A |
6/30/2022 | N/A | -60 | -49 | -49 | N/A |
3/31/2022 | N/A | -55 | -45 | -45 | N/A |
12/31/2021 | N/A | -52 | -53 | -52 | N/A |
9/30/2021 | N/A | -42 | -49 | -49 | N/A |
6/30/2021 | N/A | -44 | -49 | -48 | N/A |
3/31/2021 | N/A | -43 | -44 | -44 | N/A |
12/31/2020 | N/A | -35 | -38 | -38 | N/A |
9/30/2020 | N/A | -57 | -29 | -29 | N/A |
6/30/2020 | N/A | -48 | -26 | -26 | N/A |
3/31/2020 | N/A | -42 | -23 | -23 | N/A |
12/31/2019 | N/A | -42 | -19 | -19 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: GLTO is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: GLTO is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: GLTO is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: GLTO is forecast to have no revenue next year.
High Growth Revenue: GLTO is forecast to have no revenue next year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if GLTO's Return on Equity is forecast to be high in 3 years time
Discover growth companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/27 16:45 |
End of Day Share Price | 2024/12/27 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Galecto, Inc. is covered by 4 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Alec Stranahan | BofA Global Research |
Kristen Kluska | Cantor Fitzgerald & Co. |
Thomas Smith | Leerink Partners LLC |